Episode 92: Doxorubicin: The Infamous Red Devil
ONS member Christine Rimkus, RN, MSN, AOCN®, clinical nurse specialist for the Siteman Cancer Center at Washington University in St. Louis, MO, and member of the St. Louis ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss doxorubicin—otherwise known as the red devil—chemotherapy administration, what nurses need to know about vesicants in practice, and how to support and advocate for patients receiving doxorubicin treatment.
Episode Notes
Check out these resources from today’s episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil
- The Case of the Vexing Vesicant
- Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers
- Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
- Understanding and Managing Oncologic Emergencies: A Resource for Nurses (Third Edition)
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on Amazon Music, Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Spotify